TopFunds

Revvity

NYSE: RVTY

Stock price

158.35 USD

(+0%) TODAY

Health Care EquipmentMedical - Diagnostics & Research
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
1.9
2.1
1
2.1
2
6.5
8.1
4.5
(0.9)
2.4
2.1
1%
02Free cash flow per share
2.3
2.9
2.2
2
2.5
7.4
11.4
4.7
0.1
4.4
4.5
7.1%
03Dividends per share
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
-
04Dividends payout, %
14.9%
13.2%
27.3%
13%
13.7%
4.3%
3.4%
6.2%
(29.5)%
11.7%
13.6%
(0.9)%
PROFIT AND LOSS STATEMENT
05Revenue
$ 2,105
$ 2,116
$ 2,257
$ 2,778
$ 2,884
$ 3,783
$ 3,828
$ 3,312
$ 2,751
$ 2,755
$ 2,856
3.1%
06% Change
-
0.5%
6.7%
23.1%
3.8%
31.2%
1.2%
(13.5)%
(17)%
0.2%
3.7%
3.1%
07Cost of revenue
(1,175)
(1,143)
(1,228)
(1,527)
(1,591)
(1,792)
(1,546)
(1,551)
(1,428)
(1,432)
(1,340)
1.3%
08Gross profit
930
972.3
1,029
1,251
1,293
1,991
2,282
1,761
1,322
1,323
1,516
5%
09% Margin
44.2%
46%
45.6%
45%
44.8%
52.6%
59.6%
53.2%
48.1%
48%
53.1%
49.1% A
10Operating expenses
(663.2)
(666.6)
(724.7)
(880.3)
(887.6)
(970.7)
(941.9)
(979.6)
(922.7)
(912.1)
(1,159)
5.7%
11% of Revenue
(31.5)%
(31.5)%
(32.1)%
(31.7)%
(30.8)%
(25.7)%
(24.6)%
(29.6)%
(33.6)%
(33.1)%
(40.6)%
(31.3)% A
12Operating Income
266.8
305.7
304.6
371
405.5
1,020
1,340
781.1
399.5
410.5
356.6
2.9%
13Income tax expense
(20)
(28.4)
(139.8)
(20.2)
(9.4)
(178.3)
(314.1)
(139.2)
(3.5)
(33.1)
(25.8)
2.6%
14Net Income
212.5
233.7
113
238.8
227.6
728.1
943.2
569.2
(118.4)
295.8
241.7
1.3%
15% Margin
10.1%
11.1%
5%
8.6%
7.9%
19.3%
24.6%
17.2%
(4.3)%
10.7%
8.5%
10.8% A
16Shares Outstanding
113,315
110,313
110,859
111,534
111,501
112,085
116,674
126,426
124,812
122,822
113,214
(0)%
17EPS Basic
1.9
2.1
1
2.2
2.1
6.5
8.1
4.5
(0.9)
2.4
2.1
1%
18EPS Diluted
1.9
2.1
1
2.1
2
6.5
8.1
4.5
(0.9)
2.4
2.1
1%
19EBITDA
352.2
385.6
445.7
505.2
514.8
1,158
1,617
1,183
713.6
840.3
765.8
8.1%
% Margin
16.7%
18.2%
19.8%
18.2%
17.9%
30.6%
42.3%
35.7%
25.9%
30.5%
26.8%
25.7% A
20Net Interest Income (expense)
(37.3)
(40.8)
(41.4)
(65.8)
(62.1)
(48.7)
(99.9)
(100.4)
(26.7)
(23.1)
(61.1)
5.1%
21Net Debt / EBITDA
2.2
1.8
4
3.4
4
1.6
2.8
3.5
4.4
2.6
3.4
3.1 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
237.9
359.3
202.1
163.1
191.9
402
603.3
454.4
913.2
1,163
919.9
14.5%
23Short-term investments
-
-
-
-
-
-
-
-
689.9
-
-
-
24Accounts receivable
415.1
425.6
552.3
632.7
725.2
1,155
707.9
612.8
632.8
632.4
744.7
6%
25Other current assets
120.7
158.2
93.8
100.5
100.4
167.2
703.6
1,816
337.1
186.2
195.7
5%
26Inventory
259.5
246.8
351.7
338.3
356.9
514.6
425.9
405.5
428.1
367.6
379.5
3.9%
27Total Current Assets
1,033
1,190
1,200
1,235
1,374
2,239
2,441
3,289
3,001
2,350
2,240
8%
Non-Current Assets
28Net property, plant & equipment
137.6
145.5
298.1
318.6
485.5
575.5
649.6
671.3
664.7
649.9
644.7
16.7%
29Long-term investments
1.6
-
-
-
-
24.7
110.9
144.6
-
124.9
1.2
(3.1)%
30Other non-current assets
2,994
2,941
4,593
4,422
4,679
5,121
11,799
10,025
9,899
9,268
9,283
12%
31Total Non-Current Assets
3,133
3,087
4,892
4,741
5,164
5,721
12,560
10,841
10,564
10,043
9,929
12.2%
Total Assets
4,166
4,277
6,092
5,976
6,539
7,960
15,001
14,130
13,565
12,393
12,168
11.3%
LIABILITIES
Current Liabilities
32Accounts payable
141
168
222.1
220.9
235.9
327.3
324.8
272.8
204.1
167.5
185.5
2.8%
33Short-term debt
1.1
1.2
217.3
16.4
46.5
421.3
33.6
502.1
754.8
23.8
588.8
87.1%
34Other current liabilities
419.4
434.2
511.5
534.3
480.4
903.6
855.4
769.5
491.6
461.8
557
2.9%
35Total Current Liabilities
561.5
603.4
950.9
771.6
762.8
1,652
1,214
1,545
1,451
653.1
1,331
9%
Non-Current Liabilities
36Long-term debt
1,012
1,045
1,789
1,877
2,210
1,798
5,127
4,093
3,311
3,302
2,928
11.2%
37Other non-current liabilities
482.6
474.5
848.6
742.3
751.5
774.5
1,518
1,109
930.9
770.5
659.4
3.2%
38Total Non-Current Liabilities
1,494
1,520
2,637
2,619
2,962
2,573
6,646
5,203
4,242
4,073
3,587
9.2%
39Total Liabilities
2,056
2,123
3,588
3,391
3,725
4,225
7,859
6,747
5,692
4,726
4,918
9.1%
SHAREHOLDERS` EQUITY
40Common stock
112
109.6
110.4
110.6
111.1
112.1
126.2
126.3
123.4
120.6
112.3
-
41Retained earnings / (deficit)
1,991
2,119
2,381
2,602
2,812
3,507
4,417
4,951
5,609
5,845
6,054
11.8%
42Accumulated other comprehensive income / (loss)
(46)
(100.9)
(46.5)
(176.5)
(199.6)
(32)
(162.7)
(447.5)
(276.7)
(396.1)
(222.1)
17.1%
43Noncontrolling interests
-
-
-
-
-
-
-
-
-
-
-
-
44Total shareholders' equity
2,110
2,154
2,503
2,585
2,814
3,736
7,141
7,383
7,873
7,667
7,250
13.1%
45Total Liabilities and shareholders' Equity
4,166
4,277
6,092
5,976
6,539
7,960
15,001
14,130
13,565
12,393
12,168
11.3%
46Total Debt
1,013
1,046
2,006
1,893
2,257
2,219
5,161
4,596
4,065
3,326
3,516
13.3%
47Net Debt
775
687.2
1,804
1,730
2,065
1,817
4,557
4,141
3,152
2,162
2,596
12.9%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
212.5
233.7
113
238.8
227.6
728.1
943.2
569.2
(118.4)
295.8
241.7
1.3%
49Depreciation & amortization
105.4
100
105
180.6
214
201.6
311.4
427
431.8
427.8
405.3
14.4%
50Share-based compensation expense
17.3
17.2
25.4
28.8
31.5
26.9
29.7
51.5
41.4
37.8
22.8
2.8%
51Changes in working capital and other assets
(48)
(0.2)
45
(137.1)
(109.6)
(64.5)
126.5
(367.9)
(263.5)
(133.2)
(88.1)
6.3%
52Net cash flows from operating activities
287.1
350.6
288.5
311
363.5
892.2
1,411
679.8
91.3
628.3
581.8
7.3%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(28.2)
(31.7)
(39.1)
(93.3)
(81.3)
(63.6)
(86)
(85.6)
(81.4)
(86.6)
(73.5)
10.1%
54Purchases of investments / marketable securities
-
-
(10.8)
(7)
(6.4)
(20.1)
(23.1)
(47.2)
(1,228)
(6.6)
(0.4)
-
55Proceeds from maturities of marketable securities
-
-
36.5
-
-
-
-
8.9
550
712.5
-
-
56Other investing activities
(72.6)
(52.2)
(1,253)
(59.6)
(399.9)
(420.8)
(4,004)
(8.9)
2,073
156.9
56.6
-
57Net cash flows from investing activities
(100.9)
(83.9)
(1,267)
(159.9)
(487.6)
(504.5)
(4,113)
(132.9)
1,314
776.2
(17.4)
(16.1)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(76.4)
(151.8)
(3.8)
(57.4)
(6.3)
30.7
(48)
(66.5)
(388.9)
(369.6)
(817.9)
26.8%
59Dividends paid, net
(31.6)
(30.8)
(30.8)
(31)
(31.1)
(31.2)
(32.4)
(35.3)
(35)
(34.5)
(32.8)
0.4%
60Debt issuance (repayments), net
(35.1)
63.1
822.2
(66)
208.9
(187.5)
3,043
(559.2)
(517.5)
(723.1)
(0.5)
(34.4)%
61Other financing activities
35.9
4.5
(5.3)
(24.7)
(21.4)
(14.9)
(21)
(0.8)
(5.8)
(1.1)
(3.8)
-
62Net cash flows from financing activities
(107.1)
(115)
782.2
(179.2)
150.1
(202.9)
2,942
(661.8)
(947.1)
(1,128)
(855)
23.1%
63Increase (decrease) in cash and cash equivalents
63.1
121.3
(157.1)
(36.1)
25.6
210.7
216.7
(148.6)
443.6
250.1
(244.6)
-
64Cash and equivalents, ending balance
237.9
359.3
202.1
166.3
191.9
402.6
619.3
470.7
914.4
1,165
919.9
14.5%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
258.9
318.9
249.4
217.8
282.1
828.5
1,325
594.2
9.9
541.7
508.3
7%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
20252024202320222021201920182017

Revvity (RVTY) financial statements and performance

Explore Revvity (RVTY) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.